期刊文献+

胰高糖素样肽-1通过修饰叉头状转录因子O1磷酸化位点影响脂肪肝细胞中的脂质代谢 被引量:1

Effect of glucagon-like peptide-1 on lipid metabolism in hepatocytes by modification of forkhead box protein O1 phosphorylation sites
原文传递
导出
摘要 目的探讨胰高糖素样肽-1(GLP-1)是否能够通过修饰叉头状转录因子O1(FoxO1)磷酸化位点调控肝细胞中的脂质代谢。方法利用人肝癌细胞系HepG2细胞构建脂肪肝细胞模型[溶于异丙醇的无白蛋白棕榈酸组(PA组)]。GLP-1处理脂肪肝细胞模型后(GLP-1处理组)测定细胞内甘油三酯(TG)的变化;利用Western blot检测细胞内FoxO1三个磷酸化Thr24、Ser256和Ser319的变化;构建和转染FoxO1-Ser256突变质粒,利用RT-PCR检测GLP-1对调脂基因ACC和Fasn mRNA表达的影响。多组间比较采用方差分析,2组间比较采用t检验。结果与PA组比较,GLP-1处理组ACC和Fasn mRNA显著降低(分别为1.33±0.30比4.21±0.66、1.41±0.48比3.05±0.67,t=5.31、4.16,均P<0.05)。与PA组比较,GLP-1处理显著升高ser256和ser319位点磷酸化水平(t=7.34、8.79,均P<0.05)。转染FoxO1野生型质粒入HepG2细胞脂肪变性模型中后,GLP-1可显著降低ACC和Fasn的mRNA表达(t=5.28、4.33,均P<0.05)。而转染突变质粒FoxO1-MT入HepG2细胞脂肪变性模型中后,GLP-1不能抑制ACC和Fasn的mRNA表达(F=1.16、2.51,均P>0.05)。结论GLP-1可能通过修饰FoxO1的磷酸化位点影响其下游调脂基因ACC和Fasn的表达,进而减少脂肪肝细胞模型中TG的合成。 ObjectiveTo investigate whether glucagon-like peptide-1 (GLP-1) can regulate lipid metabolism in hepatocytes by modifying forkhead box protein O1 (FoxO1) phosphorylation sites.MethodsThe hepatic carcinoma cell line HepG2 cells were used to construct the hepatic steatosis model. Measuring the change of intracellular triglyceride (TG) of the GLP-1 treated cells fatty liver model, Western blot was used to detect changes in phosphorylation of Thr24, Ser256, and Ser319 in FoxO1;construction and transfection of the FoxO1-Ser256 mutant plasmid, RT-PCR was used to detect the changes of ACC and Fasn genes regulated by FoxO1.ResultsCompared with model group, ACC and Fasn mRNA level were lower than in GLP-1 treated model group, the difference was statistically significant (1.33±0.30 vs 4.21±0.66, 1.41±0.48 vs 3.05±0.67, t=5.31,4.16, all P<0.05). Compared with model group, the phosphorylation levels of ser256 and ser319 significantly elevated in GLP-1 group (t=7.34, 8.79, all P<0.05). After transfected with FoxO1-WT, the expression of ACC and Fasn mRNA were reduced in GLP-1 group (t=5.28, 4.33, all P<0.05). After transfected with FoxO1-MT, the expression of ACC and Fasn mRNA were not reduced in GLP-1 group (t=1.16, 2.51, all P>0.05).ConclusionsGLP-1 may affect the expression of Foxol downstream gene ACC andFasn by modifying the phosphorylation sites of FoxO1, and reduce lipid formation in the fatty liver cell model.
作者 李玲 王晓凤 张兰予 查敏 朱照华 邹大进 Li Lin;Wang Xiaofen;Zhang Lanyu;Zha Min;Zhu Zhaohua;Zou Dajin(Endocrinology Department of People's Liberation Army 401 Hospital,Qingdao 266071, China;Endocrinology Department of Changhai Hospital Affiliated to Naval Medical University,Shanghai 200433,China)
出处 《中华糖尿病杂志》 CAS CSCD 北大核心 2019年第1期58-62,共5页 CHINESE JOURNAL OF DIABETES MELLITUS
基金 国家自然科学基金(81300681).
关键词 非酒精性肝病 胰高糖素样肽 叉头状转录因子 磷酸化 Non-alcoholic fatty liver disease Glucagon-like peptide Forkhead box protein O1 Phosphorylation
  • 相关文献

参考文献2

二级参考文献17

  • 1Weickert MO, Pfeiffer AF. Signalling mechanisms linkinghepatic glucose and lipidmetabolism[J]. Diabetologia, 2006, 49(8):1732-1741.DOI: 10.1007/s00125-006-0295-3.
  • 2Samuel VT,SHulman GI. Mechanisms for insulin resistance:common threads and missing linksfj]. Cell, 2012,148(5): 852-871.DOI: 10.1016/j. cell.2012.02.017.
  • 3Pereira S, Park E, Mori Y, et al. FFA-induced hepatic insulinresistance in vivo is mediated by PKCS, NADPH oxidase, andoxidative stress[J]. Am J Physiol Endocrinol Metab, 2014, 307(1): E34-46. D01:10.1152/ajpendo.00436.2013.
  • 4Kuhrt D,Wojchowski DM.Emerging EPO and EPO receptorregulators and signal transducers[J]. Blood, 2015,125(23):3536-3541.DOI:10.1182/blood-2014-l 1-575357.
  • 5Rasic- Milutinovic Z, Perunicic- Pekovic G,Cavala A, et al.The effect of combinant human erythropoietin treatment oninsulin resistance and inflammation markers in non_ diabeticpatients on maintenance hemodialysis[J]. Hippokratia, 2008,12(3): 157-161.
  • 6Meng R,Zhu D,Bi Y, et al. Erythropoietin inhibitsgluconeogenesis and inflammation Erythropoietin in the liverand improves glucose intolerance in high-fat diet-fed mice[J].PLoS One, 2013,8(1): e53557. D01:10.1371/joumal.pone.0053557.
  • 7Gao D’Nong S,Huang X, et al. The effects of palmitate onhepatic insulin resistanceare mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPKpathways[J]. J Biol Chem, 2010, 285(39):29965-29973. DOI:10.1074/jbc.M110.128694.
  • 8Allegra V, Mengozzi G, Martimbianco L, et al. Early and lateeffects of erythropoietin on glucose metabolism inmaintenance hemodialysis patients[J]. Am J Nephrol, 1996,16(4): 304-308.
  • 9Khedr E, El- Sharkawy M, Abdulwahab S,et al. Effect ofrecombinant human erythropoietin on insulin resistance inhemodialysis patients[J]. Hemodial Int, 2009, 13(3): 340-346.DOI: 10.1111/j. 1542-4758.2009.00367.X.
  • 10Tuzcu A, Bahceci M, Yilmaz E, et al. The comparison ofinsulin sensitivity in non- diabetic hemodialysis patientstreated with and without recombinant human erythropoietin[J].Horm Metab Res,2004,36(10):716-720.DOI: 10.1055/s-2004-826021.

共引文献9

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部